ClassID:

112321

C12N2840/102 - CPC Classification

Classification description:

Vectors comprising a special translation-regulating system regulates levels of translation inhibiting translation

Recent Application in this class:
#1
20250297208
2025-09-25

YEAST WITH ENHANCED ASTAXANTHIN

#2
20250027056
2025-01-23

Adeno-Associated-Virus Rep Sequences, Vectors and Viruses

#3
20230002777
2023-01-05

Production System

#4
20220395585
2022-12-15

RNA-BASED LOGIC CIRCUITS WITH RNA BINDING PROTEINS, APTAMERS AND SMALL MOLECULES

#5
20220162571
2022-05-26

GM3 SYNTHASE VECTORS AND USES THEREOF

#6
20210332331
2021-10-28

Adeno-Associated-Virus Rep Sequences, Vectors and Viruses

#7
20210205476
2021-07-08

Isolation of novel AAV's and uses thereof

#8
20210163928
2021-06-03

MESSENGER RNA COMPRISING FUNCTIONAL RNA ELEMENTS

#9
20210163898
2021-06-03

MITOCHONDRIAL RNA IMPORT FOR TREATING MITOCHONDRIAL DISEASE

#10
20210130414
2021-05-06

TREATING CANCER WITH VIRAL NUCLEIC ACID

#11
20200216842
2020-07-09

CONDITIONAL PROTEIN TRANSLATION SWITCHES, CONDITIONAL GENE EXPRESSION SYSTEMS AND USES THEREOF

#12
20200102578
2020-04-02

Viral vector production system

#13
20190292525
2019-09-26

Adeno-associated-virus Rep sequences, vectors and viruses

#14
20190282709
2019-09-19

Isolation of novel AAV's and uses thereof

#15
20190256866
2019-08-22

Method for expressing protein gene in response to expression of miRNA

#16
20190151474
2019-05-23

RNA-based logic circuits with RNA binding proteins, aptamers and small molecules

#17
20190112600
2019-04-18

CONDITIONAL PROTEIN TRANSLATION SWITCHES, CONDITIONAL GENE EXPRESSION SYSTEMS AND USES THEREOF

#18
20180296702
2018-10-18

RNA-based logic circuits with RNA binding proteins, aptamers and small molecules

#19
20180215794
2018-08-02

Treating cancer with viral nucleic acid

#20
20180187200
2018-07-05

Recombinant Cells and Organisms Having Persistent Nonstandard Amino Acid Dependence and Methods of Making Them

#21
20170298350
2017-10-19

Methods and compositions for use of non-coding RNA in cell culturing and selection

#22
20170202979
2017-07-20

TERMINAL MODIFICATIONS OF POLYNUCLEOTIDES

#23
20170166927
2017-06-15

Isolation of novel AAV's and uses thereof

#24
20170165377
2017-06-15

Isolation of novel AAV's and uses thereof

#25
20170037431
2017-02-09

In vivo Gene Engineering with Adenoviral Vectors

#26
20170002379
2017-01-05

Synthetic genes and genetic constructs

#27
20160333373
2016-11-17

Viral vector production system

#28
20160304903
2016-10-20

Promoter-regulated differentiation-dependent self-deleting cassette

#29
20160230176
2016-08-11

Recombinant cells and organisms having persistent nonstandard amino acid dependence and methods of making them

#30
20160160221
2016-06-09

Stringent selectable markers

#31
20160150767
2016-06-02

miRNA-regulated differentiation-dependent self-deleting cassette

#32
20160002607
2016-01-07

Adeno-associated-virus Rep sequences, vectors and viruses

#33
20150299271
2015-10-22

Treating cancer with viral nucleic acid

#34
20150232530
2015-08-20

Method for expression of specific gene

#35
20150099296
2015-04-09

Promoter-regulated differentiation-dependent self-deleting cassette

#36
20140296324
2014-10-02

Vectors harboring toxic genes, methods and uses therefor

#37
20140242033
2014-08-28

Gene therapy vectors and cytosine deaminases

#38
20140189900
2014-07-03

miRNA-regulated differentiation-dependent self-deleting cassette

#39
20130312129
2013-11-21

Promoter-regulated differentiation-dependent self-deleting cassette

#40
20130312128
2013-11-21

Promoter-regulated differentiation-dependent self-deleting cassette

#41
20130298264
2013-11-07

Synthetic genes and genetic constructs

#42
20130029342
2013-01-31

GLYCINE RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH GLYCINE RIBOSWITCHES

#43
20120156672
2012-06-21

Stringent selectable markers

#44
20120135517
2012-05-31

Synthetic genes and genetic constructs

#45
20110287039
2011-11-24

Expression system for modulating an immune response

#46
20110237652
2011-09-29

Detection and destruction of cancer cells using programmed genetic vectors

#47
20110218234
2011-09-08

Gene vector for inducing transgene-specific immune tolerance

#48
20110217267
2011-09-08

Gene therapy vectors and cytosine deaminases

#49
20110123993
2011-05-26

Expression vector for mass production of foreign gene-derived protein using animal cell and use thereof

#50
20110041197
2011-02-17

Promoter-regulated differentiation-dependent self-deleting cassette

#51
20110041196
2011-02-17

miRNA-regulated differentiation-dependent self-deleting cassette

#52
20100273213
2010-10-28

Method for expression of specific gene

#53
20100186103
2010-07-22

Isolation of novel AAV'S and uses thereof

#54
20100175141
2010-07-08

Tunable genetic switch for regulating gene expression

#55
20100111873
2010-05-06

TREATING CANCER WITH VIRAL NUCLEIC ACID

#56
20090203141
2009-08-13

Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant RNA agents

#57
20090187997
2009-07-23

Cre-lox based gene knockdown constructs and methods of use thereof

#58
20090117545
2009-05-07

Glycine riboswitches, methods for their use, and compositions for use with glycine riboswitches Cross-Reference to Related Applications

#59
20070054872
2007-03-08

REGULATABLE OR CONDITIONAL EXPRESSION SYSTEMS

#60
20050250208
2005-11-10

Control of gene expression